Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Extracorporal low-density lipoprotein elimination by immunoadsorption.

M M Ritter1, K G Parhofer

  • 1Medizinische Klinik, Klinikum Ibbenbüren, Ibbenbüren, Germany. M.Ritter@Krankenhaus-Ibbenbueren.de

Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
|August 20, 2003
PubMed
Summary

Low-density lipoprotein (LDL) apheresis helps patients with coronary heart disease when cholesterol goals aren't met. Immunoadsorption, an affinity chromatography method, has unique pros and cons for patient selection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Lipidology update : Evidence-based treatment of dyslipidemia].

Der Internist·2020
Same author

MMW Fortschritte der Medizin·2020
Same author

MMW Fortschritte der Medizin·2020
Same author

Impact of perceptions of body size on obesity and weight management behaviour: a large representative population study in an African setting.

Journal of public health (Oxford, England)·2019
Same author

MMW Fortschritte der Medizin·2019
Same author

MMW Fortschritte der Medizin·2019

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry

Background:

  • Coronary heart disease (CHD) management often requires lowering low-density lipoprotein (LDL) cholesterol.
  • Some patients with CHD do not reach target LDL cholesterol levels with standard therapies.
  • LDL apheresis is an established extracorporeal treatment for severe hypercholesterolemia.

Purpose of the Study:

  • To review the therapeutic utility of LDL apheresis in patients with CHD.
  • To discuss immunoadsorption as a specific apheresis technique.
  • To highlight the advantages and disadvantages of immunoadsorption for patient selection.

Main Methods:

  • Review of existing literature on LDL apheresis and immunoadsorption.
  • Discussion of the principles of affinity chromatography used in immunoadsorption.

Related Experiment Videos

  • Analysis of clinical data and guidelines related to apheresis therapy.

    • Main Results:

    • LDL apheresis is effective for patients with CHD unresponsive to conventional lipid-lowering treatments.
    • Immunoadsorption, the first commercial apheresis technique, utilizes affinity chromatography.
    • The selection of an apheresis method requires careful consideration of individual patient factors, including the specific benefits and drawbacks of immunoadsorption.

    Conclusions:

    • LDL apheresis offers a valuable therapeutic option for select CHD patients.
    • Immunoadsorption is a key technique with distinct characteristics.
    • Personalized patient management is crucial when choosing among available apheresis strategies.